Cadila Healthcare
Cadila Healthcare gets DCGI nod to conduct phase 3 trials for two-dose COVID vaccine
The company has got the permission for conduct of phase III trials for two-dose Covid vaccine, Cadila Healthcare said in a regulatory filing
Aurobindo unit gets 14 observations
Given the sizeable number of observations, it has overshadowed the company’s decent September quarter numbers.
Cadila’s Moraiya facility gets FDA warning letter
As per the company, there were no repeat observations or Data Integrity related observations.
Zydus Pharma recalls 44.800 bottles of antidepressant in US
USFDA said Zydus Pharmaceuticals USA Inc is recalling the Paroxetine tablets in the strength of 30 mg.
Cadila and Supernus Pharma to settle patent litigation
The pact is regarding Trokendi XR extended-release capsules, used for treatment of seizures.
1 of 1